See more : Fulcrum Therapeutics, Inc. (FULC) Income Statement Analysis – Financial Results
Complete financial analysis of NCS Testing Technology Co., Ltd. (300797.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NCS Testing Technology Co., Ltd., a leading company in the Industrial – Machinery industry within the Industrials sector.
- EssilorLuxottica Société anonyme (ESLOY) Income Statement Analysis – Financial Results
- Nippon Pillar Packing Co., Ltd. (6490.T) Income Statement Analysis – Financial Results
- Seamec Limited (SEAMECLTD.NS) Income Statement Analysis – Financial Results
- B. Riley Financial, Inc. – 6.50 (RILYN) Income Statement Analysis – Financial Results
- Adveritas Limited (AV1.AX) Income Statement Analysis – Financial Results
NCS Testing Technology Co., Ltd. (300797.SZ)
About NCS Testing Technology Co., Ltd.
NCS Testing Technology Co., Ltd. provides third-party testing services in China. It offers testing services, including chemical composition testing, mechanical property testing, material failure analysis, nondestructive testing, and measurement calibration services, as well as proficiency testing services. The company also develops and sells analysis and testing instruments, NDT equipment, certified reference materials, and other products; and provides anti-corrosion products, as well as related engineering projects. In addition, it provides technical support for nuclear power, commercial aircraft, China emergency analysis, and production safety accident investigation. The company was founded in 2001 and is headquartered in Beijing, China. NCS Testing Technology Co., Ltd. is a subsidiary of China Iron and Steel Research Institute Technology Group Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 949.53M | 815.42M | 701.64M | 585.46M | 546.42M | 505.58M | 398.23M | 370.90M | 365.96M |
| Cost of Revenue | 504.56M | 436.66M | 382.29M | 332.22M | 312.87M | 288.54M | 229.94M | 210.95M | 214.37M |
| Gross Profit | 444.97M | 378.76M | 319.34M | 253.24M | 233.55M | 217.04M | 168.29M | 159.94M | 151.59M |
| Gross Profit Ratio | 46.86% | 46.45% | 45.51% | 43.26% | 42.74% | 42.93% | 42.26% | 43.12% | 41.42% |
| Research & Development | 102.61M | 101.34M | 59.31M | 44.40M | 45.81M | 49.33M | 45.35M | 40.50M | 34.65M |
| General & Administrative | 56.96M | 43.37M | 32.44M | 26.46M | 20.43M | 17.03M | 13.00M | 11.10M | 64.28M |
| Selling & Marketing | 53.41M | 102.53M | 96.81M | 74.28M | 71.16M | 67.30M | 57.41M | 55.32M | 54.21M |
| SG&A | 239.46M | 145.90M | 129.25M | 100.74M | 91.59M | 84.33M | 70.41M | 66.42M | 118.48M |
| Other Expenses | -1.24M | -550.68K | 3.09M | 5.18M | 7.20M | 1.63M | 1.80M | 22.64M | 27.06M |
| Operating Expenses | 340.83M | 285.65M | 221.54M | 164.48M | 162.23M | 147.54M | 119.04M | 129.57M | 122.07M |
| Cost & Expenses | 845.40M | 722.31M | 603.83M | 496.70M | 475.11M | 436.08M | 348.98M | 340.52M | 336.44M |
| Interest Income | 3.19M | 1.42M | 1.06M | 1.17M | 451.67K | 303.56K | 646.19K | 1.43M | 0.00 |
| Interest Expense | 6.30M | 6.55M | 7.21M | 3.58K | 415.88K | 244.76K | 378.40K | 181.86K | 0.00 |
| Depreciation & Amortization | 68.80M | 57.92M | 48.10M | 18.22M | 15.62M | 13.48M | 12.06M | 9.58M | 8.26M |
| EBITDA | 178.85M | 160.04M | 143.37M | 105.14M | 93.67M | 82.68M | 59.45M | 39.81M | 37.78M |
| EBITDA Ratio | 18.84% | 17.59% | 20.86% | 19.09% | 15.87% | 16.14% | 16.15% | 11.83% | 11.27% |
| Operating Income | 104.14M | 95.69M | 87.76M | 81.55M | 70.85M | 70.30M | 45.60M | 27.74M | 27.65M |
| Operating Income Ratio | 10.97% | 11.73% | 12.51% | 13.93% | 12.97% | 13.91% | 11.45% | 7.48% | 7.56% |
| Total Other Income/Expenses | -37.05K | -550.68K | 3.09M | 5.18M | 7.20M | 1.63M | 1.80M | 22.64M | 27.06M |
| Income Before Tax | 104.10M | 95.14M | 90.85M | 86.73M | 78.05M | 71.94M | 47.40M | 50.38M | 54.71M |
| Income Before Tax Ratio | 10.96% | 11.67% | 12.95% | 14.81% | 14.28% | 14.23% | 11.90% | 13.58% | 14.95% |
| Income Tax Expense | 3.18M | 1.33M | 6.68M | 9.58M | 8.95M | 7.69M | 5.34M | 5.72M | 7.26M |
| Net Income | 125.70M | 113.84M | 84.19M | 77.22M | 69.14M | 64.23M | 42.05M | 44.67M | 47.49M |
| Net Income Ratio | 13.24% | 13.96% | 12.00% | 13.19% | 12.65% | 12.70% | 10.56% | 12.04% | 12.98% |
| EPS | 0.34 | 0.31 | 0.23 | 0.21 | 0.19 | 0.23 | 0.15 | 0.12 | 0.13 |
| EPS Diluted | 0.33 | 0.31 | 0.23 | 0.21 | 0.19 | 0.23 | 0.15 | 0.12 | 0.13 |
| Weighted Avg Shares Out | 372.30M | 372.30M | 372.30M | 372.30M | 372.30M | 279.25M | 279.22M | 372.30M | 372.30M |
| Weighted Avg Shares Out (Dil) | 376.45M | 372.30M | 372.30M | 372.30M | 372.30M | 279.25M | 279.22M | 372.30M | 372.30M |
Source: https://incomestatements.info
Category: Stock Reports